-
10x Genomics Scheduled to Present at 46th Annual TD Cowen Health Care Conference
NASDAQ: $TXG 10x Genomics, Inc., a prominent innovator in the fields of single cell and spatial biology, has confirmed its participation in a significant industry event next month. The company announced that key members of its management team are slated to present at the highly anticipated 46th Annual TD Cowen Health Care Conference. The scheduled…
-
Compugen Set to Present at Key Investor Conferences in Early 2026
NASDAQ: $CGEN Compugen Ltd., a clinical-stage company pioneering cancer immunotherapy through advanced AI/ML-powered computational drug target discovery, has announced its management team will be participating in two significant investor conferences in the coming months. These appearances offer an important opportunity for stakeholders to gain insight into the company’s progress across its differentiated pipeline. The first…
-
QuidelOrtho Announces Presentation at Prestigious Raymond James 47th Annual Institutional Investor Conference
NASDAQ: $QDEL QuidelOrtho Corporation, a recognized global leader in innovative in vitro diagnostics, has officially announced its participation in a significant industry event: the Raymond James 47th Annual Institutional Investor Conference. This presentation offers a valuable opportunity for investors, analysts, and industry stakeholders to gain direct insight into the company’s strategic direction, recent performance, and…
-
Decoy Therapeutics Highlights Global Access Commitment Following Investor Presentation
NASDAQ: $DCOY Decoy Therapeutics Showcases Commitment to Global Accessibility During Recent Investor Event Decoy Therapeutics, Inc. recently participated in a dedicated segment during a virtual investor conference, focusing a significant portion of its presentation on the implications and execution strategy of its recently announced Global Access Commitment Agreement. The company utilized this platform to elaborate…
-
Legend Biotech Announces Key Data Presentation for CARVYKTI at 2026 Tandem Meetings
NASDAQ: $LEGN Advancing the Frontier: Legend Biotech Prepares for Major Data Showcase Legend Biotech Corporation (NASDAQ: $LEGN) has recently announced an important upcoming event that underscores their commitment to innovative cancer therapies. According to a press release dated January 21, 2026, the company will be presenting new data concerning its groundbreaking therapy, CARVYKTI® (ciltacabtagene autoleucel),…
-
Orphai Therapeutics’ LAM-001 Study Chosen for Key Presentation at ATS 2026
Orphai Therapeutics has achieved a significant milestone this week with the announcement that their Phase 2a clinical trial data for LAM-001 will be presented orally at the prestigious American Thoracic Society (ATS) 2026 International Conference. This selection is a strong indicator of the potential importance of their findings within the respiratory medicine community. Understanding the…
-
Clene’s Upcoming Presentation at the Emerging Growth Conference: What Investors Should Know
NASDAQ: $CLNN Clene Inc., a clinical-stage company focused on developing treatments that target neurodegeneration and inflammation, has announced its participation in a significant industry event. The company is scheduled to present at the Emerging Growth Conference, as detailed in their recent press release. The Significance of the Emerging Growth Conference The Emerging Growth Conference (EGC)…
-
Abpro’s ABP-102 Takes Center Stage at J.P. Morgan Healthcare Conference via Celltrion Presentation
NASDAQ: $ABP The recent announcement surrounding Abpro Therapeutics’ lead product candidate, ABP-102, has generated considerable excitement within the biotechnology sector. According to a press release published on GlobeNewswire, details regarding this promising program were prominently featured during a presentation by Celltrion Healthcare Co., Ltd. at the prestigious 44th Annual J.P. Morgan Healthcare Conference. For those…
-
Ascentage Pharma Shares Vision for Global Expansion at J.P. Morgan Conference
NASDAQ: $AAPG The recent 44th Annual J.P. Morgan Healthcare Conference served as a pivotal stage for Ascentage Pharma to articulate its comprehensive strategy for worldwide growth and innovation. The company, a dynamic force in the biopharmaceutical sector, used its presentation slot to detail how it plans to propel its pipeline from clinical promise to global…
-
Centessa Pharmaceuticals Expands Orexin Receptor Pipeline into Neuropsychiatric Territory
NASDAQ: $CNTA Centessa Pharmaceuticals recently made a significant announcement regarding the expansion of its pipeline, specifically leveraging its Orexin Receptor 2 (OX2R) agonist program. A press release detailed plans for a poster presentation at an upcoming scientific meeting, showcasing new preclinical data that supports moving these compounds into development for neuropsychiatric indications. For those unfamiliar,…